TY - JOUR
T1 - Secondary hyperparathyroidism
T2 - Pathophysiology and treatment
AU - Saliba, Wissam
AU - El-Haddad, Boutros
N1 - Copyright:
Copyright 2010 Elsevier B.V., All rights reserved.
PY - 2009/9
Y1 - 2009/9
N2 - Secondary hyperparathyroidism is a frequently encountered problem in the management of patients with chronic kidney disease (CKD). Its pathophysiology is mainly due to hyperphosphatemia and vitamin D deficiency and resistance. This condition has a high impact on the mortality and morbidity of dialysis patients. Early diagnosis of secondary hyperparathyroidism is crucial in the management of patients with CKD. The treatment remains a challenge for patients and their clinicians. It should include a combination of dietary phosphorus restriction, phosphate binders, vitamin D analogues, and calcimimetics.
AB - Secondary hyperparathyroidism is a frequently encountered problem in the management of patients with chronic kidney disease (CKD). Its pathophysiology is mainly due to hyperphosphatemia and vitamin D deficiency and resistance. This condition has a high impact on the mortality and morbidity of dialysis patients. Early diagnosis of secondary hyperparathyroidism is crucial in the management of patients with CKD. The treatment remains a challenge for patients and their clinicians. It should include a combination of dietary phosphorus restriction, phosphate binders, vitamin D analogues, and calcimimetics.
UR - http://www.scopus.com/inward/record.url?scp=70349097172&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=70349097172&partnerID=8YFLogxK
U2 - 10.3122/jabfm.2009.05.090026
DO - 10.3122/jabfm.2009.05.090026
M3 - Review article
C2 - 19734404
AN - SCOPUS:70349097172
SN - 1557-2625
VL - 22
SP - 574
EP - 581
JO - Journal of the American Board of Family Medicine
JF - Journal of the American Board of Family Medicine
IS - 5
ER -
